Derfor bør alle HIV- patienter – uanset raceoprindelse – før initiering af behandling med abacavir screenes for, om de er bærere af HLA- B* 5701 allel.
As a consequence, before initiating treatment with abacavir, screening for carriage of the HLA- B*5701 allele should be performed in any HIV-infected patient, irrespective of racial origin.